ArticleScientific reports2025
Clinical value of predicting relapse within 3 months in alcohol-dependent patients using fNIRS in verbal fluency task.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Neuroimaging in Addiction: Principles of Functional Near-infrared Spectroscopy and Its Emerging Role in De-addiction: A Narrative Review.Annals of neurosciences · 2026Review
- Applications of Functional Near-Infrared Spectroscopy (fNIRS) in Monitoring Treatment Response in Psychiatry: A Scoping Review.Journal of clinical medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
To investigate the hemodynamic differences in various brain regions between alcohol dependence (AlcD) patients and healthy controls during a verbal fluency task (VFT) using functional near-infrared spectroscopy (fNIRS), and to further explore the clinical predictive value of fNIRS before therapy for the outcome of relapse in AlcD patients after 3 months. A retrospective survey was conducted on 123 AlcD patients and 149 healthy controls during the same period. Baseline assessment of fNIRS was performed to analyze the hemodynamic differences between the two groups in different brain regions. During hospitalization, AlcD patients underwent a 3-week benzodiazepine substitution therapy, gradually tapering off the medication to achieve alcohol withdrawal treatment goals. Three months after discharge, we conducted follow-up phone calls to assess the relapse status of the patients. Compared to the control group, the AlcD group had significantly lower integral values in the frontal and bilateral temporal lobes, as well as lower β-values in all channels of the frontal lobe except for Ch13, and in all channels of the bilateral temporal lobes (p < 0.005), with no significant difference in the parietal lobe channel(p > 0.05). ROC (Receiver Operating Characteristic Curve) analysis for predicting relapse within 3 months showed that the area under the curve for all channels was highest (0.951, sensitivity 0.924, specificity 0.886). Patients with AlcD exhibit functional impairments in the frontal and temporal lobes. fNIRS channels in the frontal and parietal lobes based on VFT have good clinical predictive value for relapse within 3 months after pharmacotherapy in AlcD and can be applied in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.